Wang Y et al.Somatostatin receptor expression indicates improved prognosis in gastroenteropancreatic neuroendocrine neoplasm, and octreotide long-acting release is effective and safe in Chinese patients with advanced gastroenteropancreatic neuroendocrine tumors.Oncol Lett 13:1165-1174 (2017).
Pivonello C et al.Effects of the single and combined treatment with dopamine agonist, somatostatin analog and mTOR inhibitors in a human lung carcinoid cell line: an in vitro study.Endocrine N/A:N/A (2016).
Lehmann A et al.Carboxyl-terminal receptor domains control the differential dephosphorylation of somatostatin receptors by protein phosphatase 1 isoforms.PLoS One 9:e91526 (2014).
Sadowski SM et al.Detection of insulinoma using (68)Gallium-DOTATATE PET/CT: a case report.Gland Surg 3:E1-5 (2014).
Clifton-Bligh RJ et al.Improving diagnosis of tumor-induced osteomalacia with Gallium-68 DOTATATE PET/CT.J Clin Endocrinol Metab 98:687-94 (2013).
Chinezu L et al.Expression of somatostatin receptors, SSTR2A and SSTR5, in 108 endocrine pituitary tumors using immunohistochemical detection with new specific monoclonal antibodies.Hum Pathol N/A:N/A (2013).